000 | 01864 a2200445 4500 | ||
---|---|---|---|
005 | 20250514073939.0 | ||
264 | 0 | _c20031121 | |
008 | 200311s 0 0 eng d | ||
022 | _a0363-6119 | ||
024 | 7 |
_a10.1152/ajpregu.00028.2003 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChen, Qing Hui | |
245 | 0 | 0 |
_aResponses to GABA-A receptor blockade in the hypothalamic PVN are attenuated by local AT1 receptor antagonism. _h[electronic resource] |
260 |
_bAmerican journal of physiology. Regulatory, integrative and comparative physiology _cNov 2003 |
||
300 |
_aR1231-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAngiotensin II Type 1 Receptor Blockers |
650 | 0 | 4 | _aAngiotensin II Type 2 Receptor Blockers |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacology |
650 | 0 | 4 |
_aBicuculline _xanalogs & derivatives |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 | _aGABA-A Receptor Antagonists |
650 | 0 | 4 |
_aHeart Rate _xdrug effects |
650 | 0 | 4 |
_aImidazoles _xpharmacology |
650 | 0 | 4 |
_aKidney _xinnervation |
650 | 0 | 4 |
_aLosartan _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aParaventricular Hypothalamic Nucleus _xmetabolism |
650 | 0 | 4 |
_aPyridines _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptor, Angiotensin, Type 1 _xmetabolism |
650 | 0 | 4 |
_aReceptor, Angiotensin, Type 2 _xmetabolism |
650 | 0 | 4 |
_aReceptors, GABA-A _xmetabolism |
650 | 0 | 4 |
_aSympathetic Nervous System _xdrug effects |
700 | 1 | _aToney, Glenn M | |
773 | 0 |
_tAmerican journal of physiology. Regulatory, integrative and comparative physiology _gvol. 285 _gno. 5 _gp. R1231-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1152/ajpregu.00028.2003 _zAvailable from publisher's website |
999 |
_c12658305 _d12658305 |